Novartis could lose years of patent protection in the US for its blockbuster multiple sclerosis therapy Gilenya, after a federal appeals verdict went against the company. The litigation revolves ...

Award-winning senior researcher/writer with 25 years' experience writing about wellbeing, covering everything from indigestion remedies to insect repellents. Heartburn doesn’t just strike after ...